{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:38:28Z","timestamp":1781663908404,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["19JCZDJC64400"],"award-info":[{"award-number":["19JCZDJC64400"]}]},{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["19JCZDJC64400"],"award-info":[{"award-number":["19JCZDJC64400"]}]},{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["19JCZDJC64400"],"award-info":[{"award-number":["19JCZDJC64400"]}]},{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["19JCZDJC64400"],"award-info":[{"award-number":["19JCZDJC64400"]}]},{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["19JCZDJC64400"],"award-info":[{"award-number":["19JCZDJC64400"]}]},{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["19JCZDJC64400"],"award-info":[{"award-number":["19JCZDJC64400"]}]},{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["19JCZDJC64400"],"award-info":[{"award-number":["19JCZDJC64400"]}]},{"name":"Tianjin Northern Medicine Development Foundation","award":["TJNMDF2020YB-01"],"award-info":[{"award-number":["TJNMDF2020YB-01"]}]},{"name":"Tianjin Northern Medicine Development Foundation","award":["TJNMDF2020YB-01"],"award-info":[{"award-number":["TJNMDF2020YB-01"]}]},{"name":"Tianjin Northern Medicine Development Foundation","award":["TJNMDF2020YB-01"],"award-info":[{"award-number":["TJNMDF2020YB-01"]}]},{"name":"Tianjin Northern Medicine Development Foundation","award":["TJNMDF2020YB-01"],"award-info":[{"award-number":["TJNMDF2020YB-01"]}]},{"name":"Tianjin Northern Medicine Development Foundation","award":["TJNMDF2020YB-01"],"award-info":[{"award-number":["TJNMDF2020YB-01"]}]},{"name":"Tianjin Northern Medicine Development Foundation","award":["TJNMDF2020YB-01"],"award-info":[{"award-number":["TJNMDF2020YB-01"]}]},{"name":"Tianjin Northern Medicine Development Foundation","award":["TJNMDF2020YB-01"],"award-info":[{"award-number":["TJNMDF2020YB-01"]}]},{"name":"Tianjin Natural Science Foundation of Key Program","award":["19JCZDJC35500"],"award-info":[{"award-number":["19JCZDJC35500"]}]},{"name":"Tianjin Natural Science Foundation of Key Program","award":["19JCZDJC35500"],"award-info":[{"award-number":["19JCZDJC35500"]}]},{"name":"Tianjin Natural Science Foundation of Key Program","award":["19JCZDJC35500"],"award-info":[{"award-number":["19JCZDJC35500"]}]},{"name":"Tianjin Natural Science Foundation of Key Program","award":["19JCZDJC35500"],"award-info":[{"award-number":["19JCZDJC35500"]}]},{"name":"Tianjin Natural Science Foundation of Key Program","award":["19JCZDJC35500"],"award-info":[{"award-number":["19JCZDJC35500"]}]},{"name":"Tianjin Natural Science Foundation of Key Program","award":["19JCZDJC35500"],"award-info":[{"award-number":["19JCZDJC35500"]}]},{"name":"Tianjin Natural Science Foundation of Key Program","award":["19JCZDJC35500"],"award-info":[{"award-number":["19JCZDJC35500"]}]},{"name":"Tianjin Natural Science Foundation of Youth Program","award":["19JCQNJC12000"],"award-info":[{"award-number":["19JCQNJC12000"]}]},{"name":"Tianjin Natural Science Foundation of Youth Program","award":["19JCQNJC12000"],"award-info":[{"award-number":["19JCQNJC12000"]}]},{"name":"Tianjin Natural Science Foundation of Youth Program","award":["19JCQNJC12000"],"award-info":[{"award-number":["19JCQNJC12000"]}]},{"name":"Tianjin Natural Science Foundation of Youth Program","award":["19JCQNJC12000"],"award-info":[{"award-number":["19JCQNJC12000"]}]},{"name":"Tianjin Natural Science Foundation of Youth Program","award":["19JCQNJC12000"],"award-info":[{"award-number":["19JCQNJC12000"]}]},{"name":"Tianjin Natural Science Foundation of Youth Program","award":["19JCQNJC12000"],"award-info":[{"award-number":["19JCQNJC12000"]}]},{"name":"Tianjin Natural Science Foundation of Youth Program","award":["19JCQNJC12000"],"award-info":[{"award-number":["19JCQNJC12000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinically, thymoma patients are often complicated with myasthenia gravis (MG). Dexamethasone, a glucocorticoid with anti-inflammatory effects, could be used as an immunosuppressant for thymoma-associated MG, but the mechanism of action remains to be explored. In this study, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, weighted gene co-expression network analysis (WGCNA) of potential targets was performed by screening the intersection targets of dexamethasone and thymoma-associated MG from the database. Furthermore, the key targets and core active components were identified by topological analysis of the protein\u2013protein interaction (PPI) network. Molecular docking technology was applied to screen the complexes with stable binding of dexamethasone and core targets. Patients with thymoma were divided into two groups according to whether they received dexamethasone before operation, and immunohistochemistry and western blot were used to verify the selected target of dexamethasone in treating thymoma-associated MG. The results showed that the action pathway of dexamethasone on the disease was closely enriched to phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB\/AKT), mammalian target of rapamycin (mTOR) signaling pathways. The expressions of AKT1 and its downstream molecule mTOR in the thymoma microenvironment of thymoma-associated MG patients who did not receive dexamethasone before operation were higher than those in the group receiving dexamethasone before operation. This study demonstrates that dexamethasone can promote apoptosis through the AKT-mTOR pathway for the treatment of thymoma-associated MG, as validated by network pharmacology predictions and clinical specimen experiments, and can be verified by large-scale clinical trials in the future. This study also provides theoretical support and new research perspectives for this disease.<\/jats:p>","DOI":"10.1007\/s00210-023-02641-z","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T14:03:57Z","timestamp":1690466637000},"page":"817-828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dexamethasone improves thymoma-associated myasthenia gravis via the AKT-mTOR pathway"],"prefix":"10.1007","volume":"397","author":[{"given":"Yuxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"6","key":"2641_CR1","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/jcm11061597","volume":"11","author":"MK Alhaidar","year":"2022","unstructured":"Alhaidar MK, Abumurad S, Soliven B, Rezania K (2022) Current treatment of myasthenia gravis. J Clin Med. 11(6):1597. https:\/\/doi.org\/10.3390\/jcm11061597","journal-title":"J Clin Med."},{"issue":"6","key":"2641_CR2","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/ene.14820","volume":"28","author":"R \u00c1lvarez-Velasco","year":"2021","unstructured":"\u00c1lvarez-Velasco R, Guti\u00e9rrez-Guti\u00e9rrez G, Trujillo JC, Mart\u00ednez E, Segovia S, Arribas-Velasco M et al (2021) Clinical characteristics and outcomes of thymoma-associated myasthenia gravis. Eur J Neurol 28(6):2083\u20132091. https:\/\/doi.org\/10.1111\/ene.14820","journal-title":"Eur J Neurol"},{"issue":"6","key":"2641_CR3","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.ejcts.2007.02.032","volume":"31","author":"S Barratt","year":"2007","unstructured":"Barratt S, Puthucheary ZA, Plummeridge M (2007) Complete regression of a thymoma to glucocorticoids, commenced for palliation of symptoms. Eur J Cardiothorac Surg 31(6):1142\u20131143","journal-title":"Eur J Cardiothorac Surg"},{"key":"2641_CR4","doi-asserted-by":"publisher","first-page":"102014","DOI":"10.1016\/j.ctrv.2020.1020143","volume":"86","author":"F Conforti","year":"2020","unstructured":"Conforti F, Pala L, Giaccone G, De Pas T (2020) Thymic epithelial tumors: From biology to treatment. Cancer Treat Rev. 86:102014. https:\/\/doi.org\/10.1016\/j.ctrv.2020.1020143","journal-title":"Cancer Treat Rev."},{"key":"2641_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.biopha.2018.11.103","volume":"110","author":"S Deng","year":"2019","unstructured":"Deng S, Dai G, Chen S, Nie Z, Zhou J, Fang H et al (2019) Dexamethasone induces osteoblast apoptosis through ROS-PI3K\/AKT\/GSK3\u03b2 signaling pathway. Biomed Pharmacother 110:602\u2013608. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.103","journal-title":"Biomed Pharmacother"},{"key":"2641_CR6","doi-asserted-by":"publisher","first-page":"3056802","DOI":"10.1155\/2022\/3056802","volume":"2022","author":"P Fang","year":"2022","unstructured":"Fang P, Yu C, Liu J, Deng G, Zhang M (2022) Study on the potential mechanism of against myasthenia gravis based on network pharmacology and molecular docking with experimental verification. Evid Based Complement Alternat Med 2022:3056802. https:\/\/doi.org\/10.1155\/2022\/3056802","journal-title":"Evid Based Complement Alternat Med"},{"key":"2641_CR7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.biopha.2018.03.142","volume":"102","author":"F-B Feng","year":"2018","unstructured":"Feng F-B, Qiu H-Y (2018) Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K\/AKT\/mTOR signaling pathway in rat models with rheumatoid arthritis. Biomed Pharmacother 102:1209\u20131220. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.142","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2641_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00223-020-00687-2","volume":"107","author":"L Fu","year":"2020","unstructured":"Fu L, Wu W, Sun X, Zhang P (2020) Glucocorticoids enhanced osteoclast autophagy through the PI3K\/Akt\/mTOR signaling pathway. Calcif Tissue Int 107(1):60\u201371. https:\/\/doi.org\/10.1007\/s00223-020-00687-2","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2641_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4049\/jimmunol.1301555","volume":"193","author":"AM Gomez","year":"2014","unstructured":"Gomez AM, Willcox N, Vrolix K, Hummel J, Nogales-Gadea G, Saxena A et al (2014) Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunolog. 193(3):1055\u201363. https:\/\/doi.org\/10.4049\/jimmunol.1301555","journal-title":"J Immunolog."},{"issue":"3","key":"2641_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.4143\/crt.2015.209","volume":"48","author":"S Han","year":"2016","unstructured":"Han S, Bui NT, Ho MT, Kim YM, Cho M, Shin DB (2016) Dexamethasone inhibits TGF-\u03b21-induced cell migration by regulating the ERK and AKT pathways in human colon cancer cells Via CYR61. Cancer Res Treat 48(3):1141\u20131153. https:\/\/doi.org\/10.4143\/crt.2015.209","journal-title":"Cancer Res Treat"},{"issue":"46","key":"2641_CR11","doi-asserted-by":"publisher","first-page":"31860","DOI":"10.1074\/jbc.M109.005579","volume":"284","author":"MW Harr","year":"2009","unstructured":"Harr MW, Rong Y, Bootman MD, Roderick HL, Distelhorst CW (2009) Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors. J Biol Chem 284(46):31860\u201331871. https:\/\/doi.org\/10.1074\/jbc.M109.005579","journal-title":"J Biol Chem"},{"issue":"11","key":"2641_CR12","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.4049\/jimmunol.167.11.6225","volume":"167","author":"B Huard","year":"2001","unstructured":"Huard B, Schneider P, Mauri D, Tschopp J, French LE (2001) T cell costimulation by the TNF ligand BAFF. J Immunol (Baltimore, Md: 1950). 167(11):6225\u201331","journal-title":"J Immunol (Baltimore, Md: 1950)."},{"issue":"5","key":"2641_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10409238.2016.1215288","volume":"51","author":"J Jellusova","year":"2016","unstructured":"Jellusova J, Rickert RC (2016) The PI3K pathway in B cell metabolism. Crit Rev Biochem Mol Biol 51(5):359\u2013378","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"10","key":"2641_CR14","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/cancers12102901","volume":"12","author":"M-Y Jeon","year":"2020","unstructured":"Jeon M-Y, Woo SM, Seo SU, Kim SH, Nam J-O, Kim S et al (2020) Dexamethasone inhibits TRAIL-induced apoptosis through c-FLIP(L) upregulation and DR5 downregulation by GSK3\u03b2 activation in cancer cells. Cancers (Basel). 12(10):2901. https:\/\/doi.org\/10.3390\/cancers12102901","journal-title":"Cancers (Basel)."},{"key":"2641_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinform 9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559","journal-title":"BMC Bioinform"},{"key":"2641_CR16","doi-asserted-by":"publisher","first-page":"102337","DOI":"10.1016\/j.jaut.2019.102337","volume":"106","author":"CM Lefeuvre","year":"2020","unstructured":"Lefeuvre CM, Payet CA, Fayet O-M, Maillard S, Truffault F, Bondet V et al (2020) Risk factors associated with myasthenia gravis in thymoma patients: the potential role of thymic germinal centers. J Autoimmun 106:102337. https:\/\/doi.org\/10.1016\/j.jaut.2019.102337","journal-title":"J Autoimmun"},{"issue":"1","key":"2641_CR17","doi-asserted-by":"publisher","first-page":"14116","DOI":"10.1038\/s41598-022-17981-8","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Ding Q, Gao J, Li C, Hou P, Xu J et al (2022) Novel mechanisms underlying inhibition of inflammation-induced angiogenesis by dexamethasone and gentamicin via PI3K\/AKT\/NF-\u03baB\/VEGF pathways in acute radiation proctitis. Sci Rep 12(1):14116. https:\/\/doi.org\/10.1038\/s41598-022-17981-8","journal-title":"Sci Rep"},{"issue":"12","key":"2641_CR18","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1007\/s00415-020-10264-0","volume":"268","author":"I Lotan","year":"2021","unstructured":"Lotan I, Hellmann MA, Wilf-Yarkoni A, Steiner I (2021) Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A Systematic Review. J Neurol 268(12):4573\u20134586. https:\/\/doi.org\/10.1007\/s00415-020-10264-0","journal-title":"J Neurol"},{"key":"2641_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0179-6","volume":"3","author":"M Maurer","year":"2015","unstructured":"Maurer M, Bougoin S, Feferman T, Frenkian M, Bismuth J, Mouly V et al (2015) IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis. Acta Neuropathol Commun 3:1. https:\/\/doi.org\/10.1186\/s40478-014-0179-6","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"2641_CR20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/c3fo60076a","volume":"4","author":"M Pae","year":"2013","unstructured":"Pae M, Wu D (2013) Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications. Food Funct 4(9):1287\u20131303. https:\/\/doi.org\/10.1039\/c3fo60076a","journal-title":"Food Funct"},{"issue":"8","key":"2641_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ng.3016","volume":"46","author":"I Petrini","year":"2014","unstructured":"Petrini I, Meltzer PS, Kim I-K, Lucchi M, Park K-S, Fontanini G et al (2014) A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet 46(8):844\u2013849. https:\/\/doi.org\/10.1038\/ng.3016","journal-title":"Nat Genet"},{"key":"2641_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1196\/annals.1405.000","volume":"1132","author":"JM Ponseti","year":"2008","unstructured":"Ponseti JM, Gamez J, Azem J, L\u00f3pez-Cano M, Vilallonga R, Armengol M (2008) Tacrolimus for myasthenia gravis: a clinical study of 212 patients. Ann N Y Acad Sci 1132:254\u2013263","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2641_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","volume":"33","author":"M Radovich","year":"2018","unstructured":"Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H et al (2018) The integrated genomic landscape of thymic epithelial tumors. Cancer Cell. 33(2):244-258.e10. https:\/\/doi.org\/10.1016\/j.ccell.2018.01.003","journal-title":"Cancer Cell."},{"issue":"2","key":"2641_CR24","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/jcp.29928","volume":"236","author":"X Ruan","year":"2021","unstructured":"Ruan X, Lu X, Gao J, Jiang L, Zhu Y, Zhou Y et al (2021) Multiomics data reveals the influences of myasthenia gravis on thymoma and its precision treatment. J Cell Physiol 236(2):1214\u20131227. https:\/\/doi.org\/10.1002\/jcp.29928","journal-title":"J Cell Physiol"},{"key":"2641_CR25","doi-asserted-by":"publisher","first-page":"baq020","DOI":"10.1093\/database\/baq020","volume":"2010","author":"M Safran","year":"2010","unstructured":"Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M et al (2010) GeneCards Version 3: the human gene integrator. Database (Oxford). 2010:baq020. https:\/\/doi.org\/10.1093\/database\/baq020","journal-title":"Database (Oxford)."},{"key":"2641_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.molmet.2019.02.004","volume":"23","author":"J Sanchez-Gurmaches","year":"2019","unstructured":"Sanchez-Gurmaches J, Martinez Calejman C, Jung SM, Li H, Guertin DA (2019) Brown fat organogenesis and maintenance requires AKT1 and AKT2. Mol Metab 23:60\u201374. https:\/\/doi.org\/10.1016\/j.molmet.2019.02.004","journal-title":"Mol Metab"},{"key":"2641_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","volume":"99","author":"M Scorsetti","year":"2016","unstructured":"Scorsetti M, Leo F, Trama A, D\u2019Angelillo R, Serpico D, Macerelli M et al (2016) Thymoma and thymic carcinomas. Crit Rev Oncol Hematol 99:332\u2013350. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2641_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1056\/NEJM197401102900204","volume":"290","author":"ME Seybold","year":"1974","unstructured":"Seybold ME, Drachman DB (1974) Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med. 290(2):81\u20134","journal-title":"N Engl J Med."},{"issue":"11","key":"2641_CR29","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"issue":"1","key":"2641_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12886-020-01697-2","volume":"20","author":"M Shi","year":"2020","unstructured":"Shi M, Ye Y, Zhou J, Qin A, Cheng J, Ren H (2020) Local use of dexamethasone in the treatment of ocular myasthenia gravis. BMC Ophthalmol 20(1):432. https:\/\/doi.org\/10.1186\/s12886-020-01697-2","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"2641_CR31","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41467-017-01602-4","volume":"8","author":"J Sintes","year":"2017","unstructured":"Sintes J, Gentile M, Zhang S, Garcia-Carmona Y, Magri G, Cassis L et al (2017) mTOR intersects antibody-inducing signals from TACI in marginal zone B cells. Nat Commun 8(1):1462. https:\/\/doi.org\/10.1038\/s41467-017-01602-4","journal-title":"Nat Commun"},{"issue":"6","key":"2641_CR32","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","volume":"79","author":"M Song","year":"2019","unstructured":"Song M, Bode AM, Dong Z, Lee M-H (2019) AKT as a therapeutic target for cancer. Cancer Res 79(6):1019\u20131031. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2738","journal-title":"Cancer Res"},{"issue":"D1","key":"2641_CR33","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M et al (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45(D1):D362\u2013D368. https:\/\/doi.org\/10.1093\/nar\/gkw937","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2641_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","volume":"52","author":"F Truffault","year":"2017","unstructured":"Truffault F, de Montpreville V, Eymard B, Sharshar T, Le Panse R, Berrih-Aknin S (2017) Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035 cases and a critical review. Clin Rev Allergy Immunol 52(1):108\u2013124. https:\/\/doi.org\/10.1007\/s12016-016-8558-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"2641_CR35","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/mus.25397","volume":"55","author":"K Utsugisawa","year":"2017","unstructured":"Utsugisawa K, Nagane Y, Akaishi T, Suzuki Y, Imai T, Tsuda E et al (2017) Early fast-acting treatment strategy against generalized myasthenia gravis. Muscle Nerve 55(6):794\u2013801. https:\/\/doi.org\/10.1002\/mus.25397","journal-title":"Muscle Nerve"},{"issue":"1","key":"2641_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1056\/NEJM197201062860104","volume":"286","author":"JR Warmolts","year":"1972","unstructured":"Warmolts JR, Engel WK (1972) Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med 286(1):17\u201320","journal-title":"N Engl J Med"},{"issue":"6","key":"2641_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo H-C, Marx A et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375(6):511\u2013522. https:\/\/doi.org\/10.1056\/NEJMoa1602489","journal-title":"N Engl J Med"},{"issue":"5","key":"2641_CR38","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/ijms21051846","volume":"21","author":"L Xu","year":"2020","unstructured":"Xu L, Xia H, Ni D, Hu Y, Liu J, Qin Y et al (2020) High-dose dexamethasone manipulates the tumor microenvironment and internal metabolic pathways in anti-tumor progression. Int J Mol Sci. 21(5):1846. https:\/\/doi.org\/10.3390\/ijms21051846","journal-title":"Int J Mol Sci."},{"issue":"1","key":"2641_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12026-020-09164-2","volume":"69","author":"Y Xu","year":"2021","unstructured":"Xu Y, Huang X, Li F, Liu T, Yang T, Chen F et al (2021) IL-21 enhances STAT3\/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis. Immunol Res 69(1):59\u201370. https:\/\/doi.org\/10.1007\/s12026-020-09164-2","journal-title":"Immunol Res"},{"key":"2641_CR40","doi-asserted-by":"publisher","first-page":"105985","DOI":"10.1016\/j.phrs.2021.105985","volume":"175","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Zhang X, Wei W, Zhao J, Wu Y, Zhao S et al (2022) Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy. Pharmacol Res. 175:105985. https:\/\/doi.org\/10.1016\/j.phrs.2021.105985","journal-title":"Pharmacol Res."},{"issue":"7","key":"2641_CR41","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/jamaneurol.2016.0603","volume":"73","author":"A Zekeridou","year":"2016","unstructured":"Zekeridou A, McKeon A, Lennon VA (2016) Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma. JAMA Neurol 73(7):853\u2013859. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0603","journal-title":"JAMA Neurol"},{"issue":"6","key":"2641_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","volume":"10","author":"M Zen","year":"2011","unstructured":"Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M et al (2011) The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 10(6):305\u2013310. https:\/\/doi.org\/10.1016\/j.autrev.2010.11.009","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2641_CR43","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3892\/etm.2019.8225","volume":"19","author":"D Zhang","year":"2020","unstructured":"Zhang D, Zhang Y, Cai Z, Tu Y, Hu Z (2020) Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR\/AKT and VEGF signal pathways. Exp Ther Med 19(1):762\u2013770. https:\/\/doi.org\/10.3892\/etm.2019.8225","journal-title":"Exp Ther Med"},{"key":"2641_CR44","doi-asserted-by":"publisher","first-page":"7416448","DOI":"10.1155\/2022\/7416448","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chang T, Lu Q, Cui Y, Zhang D, Wang B et al (2022) Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug formulary for myasthenia gravis (MG) based on UHPLC-QE-MS network pharmacology and molecular docking techniques. Evid Based Complement Alternat Med 2022:7416448. https:\/\/doi.org\/10.1155\/2022\/7416448","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"2641_CR45","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s13760-021-01731-0","volume":"122","author":"V Zouvelou","year":"2022","unstructured":"Zouvelou V, Vamvakaris I, Tentolouris-Piperas V, Potaris K, Velonakis G (2022) The effect of glucocorticoids on radiology and histology of thymoma in myasthenia gravis. Acta Neurol Belg 122(4):1073\u20131075. https:\/\/doi.org\/10.1007\/s13760-021-01731-0","journal-title":"Acta Neurol Belg"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02641-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T20:02:21Z","timestamp":1705435341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2641"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02641-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}